Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.
PLoS One. 2013 Jun 13;8(6):e66982. doi: 10.1371/journal.pone.0066982. Print 2013.
Glucocorticoid-induced TNF receptor (GITR) plays a crucial role in modulating immune response and inflammation, however the role of GITR in human cancers is poorly understood. In this study, we demonstrated that GITR is inactivated during tumor progression in Multiple Myeloma (MM) through promoter CpG island methylation, mediating gene silencing in primary MM plasma cells and MM cell lines. Restoration of GITR expression in GITR deficient MM cells led to inhibition of MM proliferation in vitro and in vivo and induction of apoptosis. These findings were supported by the presence of induction of p21 and PUMA, two direct downstream targets of p53, together with modulation of NF-κB in GITR-overexpressing MM cells. Moreover, the unbalanced expression of GITR in clonal plasma cells correlated with MM disease progression, poor prognosis and survival. These findings provide novel insights into the pivotal role of GITR in MM pathogenesis and disease progression.
糖皮质激素诱导的肿瘤坏死因子受体(GITR)在调节免疫反应和炎症中起着至关重要的作用,但 GITR 在人类癌症中的作用尚不清楚。在这项研究中,我们证明 GITR 在多发性骨髓瘤(MM)的肿瘤进展过程中通过启动子 CpG 岛甲基化失活,介导原发性 MM 浆细胞和 MM 细胞系中的基因沉默。在 GITR 缺陷的 MM 细胞中恢复 GITR 表达导致体外和体内 MM 增殖的抑制和凋亡的诱导。这些发现得到了以下证据的支持:在 GITR 过表达的 MM 细胞中,p53 的两个直接下游靶标 p21 和 PUMA 的诱导,以及 NF-κB 的调节。此外,克隆性浆细胞中 GITR 的不平衡表达与 MM 疾病进展、预后不良和生存相关。这些发现为 GITR 在 MM 发病机制和疾病进展中的关键作用提供了新的见解。